vialroom

#semaglutide 2024-03-11

Monday26 messages5 participantstimes are UTC
Highlights from this day
  • mg_per_ml — does the licensed ceiling for weight differ from the diabetes one 22:00
  • ferrous_ash — compounded and brand felt the same to me at 2.5, which is one person and nothing more 22:26
  • VialBot — Purity check: no report on file for lot KP-0925. Nothing logged either way. 22:46
  • slow.taper — SELECT was cardiovascular outcomes in people with overweight and existing disease, not a weight trial 23:15
  • slow.taper — lost about 29kg on the low doses before i even got to 1, which surprised me, i think 23:19
FA

dose day is sunday for me only because thats when i remember, not because sunday matters

follow up the trials titrated on a fixed schedule, most people here dont, worth remembering when comparing
i dont think the plateau is a dose problem most of the time, but i cant prove that

does the seven day half life mean the last two days are weaker

genuine question steady state is the bit people skip, judging a new dose after eight days tells you almost nothing, anyway

MP

does the licensed ceiling for weight differ from the diabetes one

3❤️6🧪1

restarted after 1 months off at a low dose and the nausea arrived exactly like the first time, happy to be corrected

did anybody find a difference between KP and pharmacy at the same 2

MP

i dont think the plateau is a dose problem most of the time, but i cant prove that

vials not pens here

moving my dose day by a day or two never did anything noticeable for me, i think

FA

compounded and brand felt the same to me at 2.5, which is one person and nothing more

⚠️816

plateaus move

VB

Purity check: no report on file for lot KP-0925. Nothing logged either way.

⚠️3🤝11
FA

is the plateau usually appetite coming back or just the scale stopping

ST

STEP 1 ran to 68 weeks. thats the one everyone half remembers, someone check my working

does anyone actually run a five week step instead of four

ST

SELECT was cardiovascular outcomes in people with overweight and existing disease, not a weight trial

Cited study
Effects of Semaglutide on Chronic Kidney Disease in Type 2 Diabetes (FLOW)
New England Journal of Medicine · 2024
Renal outcomes. The one that changed a lot of nephrologists’ minds.
👀12🔥8

how did people handle the jump from 1 to 1.7

lost about 29kg on the low doses before i even got to 1, which surprised me, i think

👍8
23:58ferrous_ash pinned a message to this channel